Skip to main content
Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
21.46
+0.85 (4.12%)
At close: Oct 11, 2024, 4:00 PM
21.52
+0.06 (0.27%)
After-hours: Oct 11, 2024, 6:03 PM EDT

ARCT Revenue

Arcturus Therapeutics Holdings had revenue of $49.86M in the quarter ending June 30, 2024, with 373.99% growth. This brings the company's revenue in the last twelve months to $163.87M, down -38.04% year-over-year. In the year 2023, Arcturus Therapeutics Holdings had annual revenue of $166.80M, down -19.03%.

Revenue (ttm)
$163.87M
Revenue Growth
-38.04%
P/S Ratio
3.51
Revenue / Employee
$910,367
Employees
180
Market Cap
580.33M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023166.80M-39.20M-19.03%
Dec 31, 2022206.00M193.64M1,566.79%
Dec 31, 202112.36M2.82M29.56%
Dec 31, 20209.54M-11.25M-54.12%
Dec 31, 201920.79M5.04M31.97%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Orthofix Medical 771.65M
Revance Therapeutics 251.18M
Entrada Therapeutics 239.40M
SI-BONE 150.71M
Surmodics 120.82M
ABIVAX Société Anonyme 9.68M
CorMedix 806.12K
Allogene Therapeutics 65.00K
Revenue Rankings

ARCT News

More News